News & Updates

In the phase III MARIPOSA trial, the amivantamab-lazertinib cocktail outdid osimertinib as first-line (1L) treatment for EGFR-mutated, advanced non-small cell lung cancer (NSCLC).

Prolonged exposure to air pollution appears to put women at increased risk of breast cancer, according to data from the French E3N cohort.

Treatment with placebo is successful in patients with open-angle glaucoma or ocular hypertension, achieving lower intraocular pressure (IOP), compared with untreated control participants, reports a recent study.

Diabetes and higher body mass index (BMI) contribute to pathological upstaging in renal cell carcinoma, according to a study. Preoperative tumour size, increased age, and male sex are also significantly associated with upstaging.

An open-label, randomized, parallel-design clinical trial demonstrates weight loss as well as decreases in fasting glucose, insulin and insulin resistance in overweight and obese Hong Kong Chinese individuals after high-fibre dietary intervention supplemented with synbiotics.

Management of most adults with COVID-19, particularly those with mild-to-moderate disease, is increasingly occurring in the outpatient setting due to the availability of effective treatment options. 

Combined trabeculectomy with trabeculectomy (CTT) confers benefits on patients with primary congenital glaucoma (PCG), suggests a study.